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Abstract: Hypoxia is a stress factor frequently encountered during flight and a common cause of tissue and cell 
injury experienced by in-flight crew. Effects of hypoxia on the body can vary depending on the duration and severity 
of hypoxic exposure. As symptoms can differ among individuals, the measures taken to address hypoxia can be 
greatly improved by understanding its effects. It is critically important for pilots, cabin crew, and in-flight medical 
professionals to familiarize themselves with hypoxia and the factors that affect its presentation. In this study, we 
investigated the effect of hypoxia on the expression of vascular endothelial growth factor (VEGF) in mice using a 
hypoxic-exposure model. Experimental animals were placed in a hypobaric chamber at 8,000 ft for 1 h (n=5), 3 h 
(n=5), or 6 h (n=5). Immediately after hypoxic exposure, protein concentration of VEGF and mRNA levels of hypoxia-
inducible factor-1α (HIF-1α) and VEGF were analyzed in serum and liver tissue homogenates. Exposure to hypobaric 
hypoxia significantly upregulated the expression of both HIF-1α and VEGF mRNA, but not hepatic VEGF mRNA. Our 
data indicate that acute exposure to hypobaric hypoxia upregulates serum mRNA levels of HIF-1α and VEGF in mice, 
and that the liver is less likely to be the source of elevated serum VEGF mRNA. In contrast, serum VEGF protein level 
may be regulated by other factors. Further investigations to confirm or disprove our preliminary results are required.
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Introduction
Hypoxia is one of the most frequently encoun-
tered stress factors, and it is often implicated 
as a common cause of tissue and cell injury. 
Recent studies have indicated that the effects 
of hypoxia on the body can vary depending on 
the duration, severity, and frequency of hypoxic 
exposure [1]. Individuals may be exposed to 
acute or chronic hypoxia during their lifetime, 
and previous studies have reported the effects 
of hypoxia on the organs and tissues. Hypoxia 
can be observed in both physiological and 
pathophysiological conditions such as those 
encountered during severe exercise, air travel, 
obstructive sleep apnea, exposure to high alti-
tude, and various respiratory diseases [1].
The aerospace environment has negative 
effects on body functions, resulting in the mal-
function of vital organs. Flight surgeons contin-
ually seek to determine and understand the 
physiological responses of pilots to hypoxia and 
the pathophysiological mechanisms involved. 
Advances in aircraft design have made it pos-
sible to fly at increasingly higher altitudes. 
However, the possibility of experiencing hypoxia 
still exists, not only for pilots and cabin crew, 
but also for patients being transported by mili-
tary or civilian airlines [2]. As symptoms of 
hypoxia can vary among individuals, the mea-
sures taken to address hypoxia can be greatly 
improved by understanding its effects. It is criti-
cally important for pilots, cabin crew, and medi-
cal professionals to become familiar with hy- 
poxia and the factors that affect its presen- 
tation.
Vascular endothelial growth factor (VEGF), pre-
viously known as vascular permeability factor, 
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is a potent endothelial cell-specific mitogen 
involved in the regulation of vascular permea-
bility and angiogenesis [3]. When administered 
to endothelial cells in culture media, VEGF 
induces several of the steps involved in forma-
tion of new blood vessels, including prolifera-
tion and migration of endothelial cells and elici-
tation of de novo blood vessel formation. VEGF 
also triggers the production of matrix metallo-
proteinases, which are required for breakdown 
of the basement membrane and invasion of 
blood vessels into the surrounding stroma [4]. 
Hypoxia stimulates the expression of both 
VEGF and its receptors in human endothelial 
cells [5]. Xu et al. [6] demonstrated that VEGF 
expression in the brain is strongly upregulated 
by alveolar hypoxia, indicating the association 
of VEGF with the pathogenesis of high-altitude 
cerebral edema. Christou et al. [7] also ob- 
served that hypoxia significantly upregulated 
gene expression of VEGF and its receptors in 
rat lungs. Similarly, a previous human study by 
Walter et al. [8] reported that serum VEGF con-
centration significantly increased in mountain 
climbers 24 h after they reached an altitude of 
4,559 m (14,957 ft).
Commercial aircraft pressurization can provide 
a “shirt-sleeve environment” within the cabin, 
with an equivalent altitude of 8,000 ft, while 
the aircraft can operate up to approximately 
40,000 ft. In contrast, military combat aircrafts 
are pressurized to a lower degree than com-
mercial or noncombat planes, because they 
are more likely to sustain damage that can 
result in loss of pressurization [9]. At an alti-
tude of 8,000 ft, the ambient partial pressure 
of oxygen is 118.29 mmHg and alveolar oxygen 
tension is 68.9 mmHg, which are 26% and 34% 
lower than those at sea level, respectively. 
Though an altitude of 8,000 ft falls within the 
physiologically efficient zone, one can experi-
ence shortness of breath, fatigue, dizziness, 
and headache with prolonged exposure [10]. 
In this study, we used an animal hypoxic-expo-
sure model to investigate whether acute expo-
sure to hypobaric hypoxia alters the mRNA 
expression levels of hypoxia-inducible factor 
alpha (HIF-1α) and VEGF as well as VEGF pro-
tein concentration. Further, the source of ele-
vated serum VEGF mRNA was determined by 
analyzing levels of hepatic VEGF mRNA. We 
observed that acute hypoxic exposure signifi-
cantly upregulates serum mRNA levels of HIF-
1α and VEGF, suggesting a role of hypoxia in 
regulation of the VEGF signaling pathway. The 
expression pattern of hepatic VEGF mRNA did 
not correlate with change in serum VEGF mRNA 
level.
Materials and methods
Experimental animals and hypoxia exposure
An experimental scheme is shown in Figure 1. 
Twenty-five 8-yr-old C57BL/6 mice were used. 
Throughout the experimental period, the ani-
mals were fed standard laboratory mouse chow 
and provided free access to water. The animals 
were randomly divided into hypoxic and control 
(normoxic) groups. To achieve hypoxia, mice 
were placed in an altitude chamber at a baro-
metric pressure of 570 mmHg, corresponding 
to an altitude of 2,438 m (approximately 8,000 
ft). The temperature and moisture of the cham-
ber were maintained at 20°C to 24°C and 45%, 
respectively. The animals in the hypoxic groups 
(n=5 each) were exposed to these conditions 
for 1, 3, or 6 h. The mice in the control group 
(n=5) were housed in the same environment as 
the hypoxic group, with access to food and 
water ad libitum, except that they were allowed 
to breathe normal room air. Later, the mice 
were laparotomized via a midline incision to col-
lect tissue samples. Liver tissue was immedi-
ately frozen in liquid nitrogen at -80°C until 
reverse-transcriptase polymerase chain reac-
tion (RT-PCR) analysis was performed. Whole 
blood was collected by cardiac puncture and 
centrifuged at 3,000 rpm (approximately 1,000 
g) for 10 min to obtain serum. The care of ani-
mals and experimental procedures were in 
accordance with guidelines established by the 
National Institutes of Health. All procedures 
were approved by the Institutional Animal Care 
and Use Committee (IACUC) of the Republic of 
Korea Aerospace Medical Center (Cheongju, 
Chungcheongbuk-do, Republic of Korea; Pro- 
tocol No.: ASMC-14-IACUC-001).
mRNA expression of HIF-1α and VEGF
Real-time RT-PCR was carried out for HIF-1α 
and VEGF to quantify gene expression of HIF-1α 
and VEGF under hypoxia. Quantitative real-time 
RT-PCR was performed using a Bio-Rad CFX96 
Real-Time PCR Detection System (Bio-Rad 
Laboratories, Hercules, CA) with a C1000 
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Thermal Cycler (Bio-Rad Laboratories). Total 
RNA from serum and liver tissue was isolated 
using the NucleoSpin RNA II extraction kit 
(Macherey-Nagel, Dueren, Germany), according 
to the manufacturer’s instructions. cDNA syn-
thesis was performed using the ReverTra Ace-
α-reverse-transcriptase kit (Toyobo, Osaka, 
Japan) according to the manufacturer’s instruc-
tions. Standard cDNA was quantified photomet-
rically. Reverse-transcribed cDNA was used for 
real-time RT-PCR using SsoAdvanced SYBR 
Green Supermix (Bio-Rad Laboratories). PCR 
was initiated with a denaturing step at 95°C for 
3 min, followed by 40 cycles at 95°C for 10 sec, 
58°C for 10 sec, and 72°C for 20 sec. A melting 
curve analysis from 65°C to 95°C was per-
formed following each RT-PCR in order to test 
for the presence of primer dimers. When prim-
er-dimer formation was detected, the PCR was 
repeated using a fresh aliquot of cDNA. Each 
measurement was repeated three times, and 
the values were used to calculate the ratios of 
HIF-1α/glyceraldehyde 3-phosphate dehydro-
genase (GAPDH) and VEGF/GAPDH, with a 
value of 1.0 used as the control (calibrator).
Measurement of serum VEGF concentration
Serum VEGF concentration was determined by 
enzyme-linked immunosorbent assay (ELISA) 
Results
Significant increases in HIF-1α mRNA expres-
sion in the serum of hypoxic mice were observed 
in the 3- and 6-h exposure groups (Figure 2A). 
Quantitative real-time RT-PCR analysis of HIF-
1α mRNA revealed 1.60-, 2.67-, and 1.88-fold 
increases in the amount of mRNA in the 1-, 3-, 
and 6-h exposure groups, respectively. 
Serum VEGF mRNA level showed a trend similar 
to that of HIF-1α mRNA expression (Figure 2B). 
Significant increases in VEGF mRNA expression 
in the serum of hypoxic mice were observed in 
the 1- and 3-h exposure groups. Quantitative 
analysis revealed 1.69-, 3.17-, and 1.36-fold 
increases in the amount of VEGF mRNA in the 
1-, 3-, and 6-h exposure groups, respectively. 
To determine the source of elevated serum 
VEGF mRNA, hepatic VEGF mRNA level was 
also analyzed. However, the time course of 
changes in hepatic VEGF mRNA level was differ-
ent from that of serum mRNA level (Figure 2C); 
a significant upregulation of hepatic VEGF 
mRNA was observed only in the 6-h exposure 
group (1.80-fold compared to the control 
group). The 1-h exposure group displayed a 
slight increase in the amount of mRNA com-
pared to the control group, whereas the 3-h 
exposure group showed a decrease below the 
Figure 1. Experimental scheme of hypoxic exposure. Experimental animals 
(n=5 each) were exposed to hypobaric hypoxia (8,000 ft) for 1, 3, or 6 h. Se-
rum and hepatic HIF-1α and VEGF mRNA levels were measured using quan-
titative real-time RT-PCR, and serum VEGF concentration was analyzed using 
ELISA.
using a VEGF (R&D Systems, 
Quantikine ELISA, MN) assay 
kit, according to the manu-
facturer’s instructions. VEGF 
level was determined by 
measuring optical density 
using a microplate reader 
(Bio-Rad Laboratories) at 
450 nm.
Statistical analysis
All values are provided as 
mean ± standard error. Diff- 
erences in the normalized 
mRNA ratio and protein con-
centration between groups 
were assessed using the Kr- 
uskal-Wallis test (SPSS ver. 
18.0 software; IBM SPSS 
Inc., Chicago, IL, USA). P val-
ues < 0.05 were considered 
statistically significant.
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basal level found in the control group. These 
results indicate that the liver is unlikely to be 
involved in the upregulation of serum VEGF 
mRNA and protein expression following hypoxic 
exposure. Similarly, the time course of altera-
tions in serum VEGF level was different from 
that of VEGF mRNA level. As shown in Figure 
2D, The mean serum VEGF level of the control 
group was 25.58±7.96 pg/mL. After hypoxic 
exposure, the levels decreased, although the 
difference was insignificant; the mean serum 
VEGF concentrations of the 1-, 3-, and 6-h 
exposure groups were 20.87±4.06, 18.61± 
1.09, and 20.15±3.33 pg/mL, respectively. 
These findings suggest that serum VEGF pro-
tein level is regulated by other factors. None of 
the mice displayed remarkable changes in 
behavior during or after exposure to hypoxia.
Discussion
We observed that mRNA expression levels of 
HIF-1α and VEGF increased significantly under 
hypobaric hypoxia. HIF-1α and VEGF mRNA lev-
els were higher in the 1- and 3-h exposure 
groups than in the control group. Additionally, 
mRNA levels increased to a greater extent in 
the 3-h exposure group than in the 1-h expo-
sure group, although the difference was not 
statistically significant. The 6-h exposure group 
Figure 2. Effect of exposure to hypoxia on the expression of HIF-1α and VEGF. (A and B) Time course of expression 
of serum HIF-1α mRNA and VEGF mRNA. Significant increases in the amount of (A) HIF-1α and (B) VEGF mRNA were 
observed in hypoxic mice. (C) Time course of expression of hepatic VEGF mRNA. The 6-h exposure group showed 
a significantly higher mRNA level than the control group, whereas the other two groups did not show a significant 
difference in VEGF mRNA level compared to the control group. (D) Time course of expression of serum VEGF con-
centration. Compared to the control group, the three experimental groups displayed lower VEGF levels, although the 
differences between the control group and each experimental group were not significant.
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showed a lower normalized ratio than the 3-h 
exposure group; however, it was still higher 
than that in the control group. These results 
suggest that exposure to hypobaric hypoxia 
triggers hypoxia-induced cellular signaling cas-
cades, including HIF-1α and VEGF signaling 
pathways. This finding indicates the possibility 
that at least 3 to 6 h is needed for physiologic 
adaptation to hypoxia at an altitude of 8,000 ft.
Results of previous studies investigating the 
effects of hypoxic exposure on serum VEGF 
concentration are controversial. Schobersbe- 
rger et al. [11] investigated the effects of 
exhaustive long-lasting exercise at moderate 
altitude on the time course of changes in serum 
VEGF level, where 13 well-trained runners who 
participated in the Swiss Alpine Marathon of 
Davos (distance, 67,000 m; altitude difference, 
2,300 m) were observed. In their study, serum 
VEGF increased significantly, immediately after 
the run, and was maintained at a significantly 
high level (up to 2.4-fold higher) until 5 d post-
exercise. In contrast, Maloney et al. [12] found 
that high-altitude VEGF level was not signifi-
cantly higher than that measured at sea level in 
mountaineers at high altitude (14,200 ft). In 
the present study, serum VEGF concentration 
was not significantly altered following hypoxic 
exposure but did decrease slightly. This result 
is consistent with that of Gunga et al. [13], who 
investigated the time course of changes in 
serum VEGF concentration during a high-alti-
tude marathon run. They showed that pro-
longed physical stress during severe hypobaric 
hypoxia decreased serum VEGF level. Serum 
VEGF concentration is determined by its pro-
duction as well as the release, removal, and 
binding of circulating VEGF [14]. Our findings of 
an insignificant association between VEGF 
mRNA expression level and VEGF protein con-
centration raises the possibility that changes in 
serum VEGF concentration after hypoxic expo-
sure may be regulated by factors other than 
transcriptional upregulation at a cellular level. 
To investigate whether the upregulation of 
serum VEGF mRNA expression was associated 
with elevated hepatic VEGF mRNA production, 
we determined VEGF mRNA levels in liver tissue 
homogenates obtained from hypoxic mice. We 
did not observe any statistically significant 
increase in hepatic VEGF mRNA compared to 
the control group, suggesting that the liver is 
unlikely to be the source of elevated serum 
VEGF mRNA. However, as only a small number 
of animals were used in the study and the expo-
sure duration was short, the possibility of an 
association between hepatic VEGF mRNA pro-
duction and serum mRNA level cannot be com-
pletely discounted. 
In conclusion, the results of the present study 
indicate that hypobaric hypoxia upregulates 
serum mRNA levels of HIF-1α and VEGF in mice. 
The liver seems unlikely to be the source of 
elevated serum VEGF mRNA. Our findings of an 
insignificant association between level of 
serum VEGF mRNA and protein concentration 
indicate that changes in serum VEGF concen-
tration after hypoxic exposure are possibly reg-
ulated by factors other than transcriptional 
upregulation. Further investigations to confirm 
or disprove our preliminary results are required.
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